EN-1001

N/A

Report date: 2023/01/07 12:17:31
NME

Base Information

Drug NameEN-1001
Drug Alias NameEN-1001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor receptor superfamily member 1A inhibitors
TargetsTumor necrosis factor receptor superfamily member 1A
Therapy Area/IndicationsInflammationAutoimmune Diseases of the Nervous SystemNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnosi Life Sciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesEnosi Life Sciences Corp
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases of the Nervous SystemNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A